Contrary to previous findings regarding APOA1 expression in lung cancer, a recent study found that APOA1 levels were increased in patients with idiopathic pulmonary fibrosis-related lung cancer, resulting in dyslipidemia [99]. Here, APOA1 is linked to metabolic syndrome.